Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 31, 2003

View Archived Issues

Cardioprotective effects of cariporide in pig model of limited ischemia/reperfusion

Drug pipeline for osteoarthritis

Antiinflammatory effects of montelukast in cystic fibrosis

Rosuvastatin superior to pravastatin or simvastatin in hypercholesterolemia trial

Immunomodulatory effects of WY-14643 demonstrated in mice

Antidepressant-like changes induced by SAMe in the brain of elderly volunteers

Novel glucose- and lipid-lowering agents in early development at Kyoto Pharmaceutical

Fujisawa describes dual adenosine A1/A2A antagonists for depression, dementia, etc.

Janssen presents novel agents for lowering intracranial pressure

New 5-HT6 antagonists with utility in obesity, NIDDM and CNS disorders

Schering presents new inhibitors of CDK and/or GSK-3

Recent Tanabe Seiyaku patent covers novel inhibitors of apo B secretion

Apoptosis-inducing glucose derivatives prepared and tested by Nisshin Seifun and Kyorin team

Medarex and diaDexus form antibody therapeutic collaboration

Tularik reports recent clinical highlights

Safety of ThGRF demonstrated in patients with type 2 diabetes

Replicon NeuroTherapeutics awarded grant for replicon development

Pharmexa reprioritizes programs

Kaleidos's TGF-alpha to be studied for AIDS by NIAID

Encouraging results reported for SomatoKine in adolescent type 1 diabetics

EDEMA1 trial for DX-88 in hereditary angioedema begins patient treatment

Phase II study to evaluate Aptosyn combination regimen in prostate cancer

Study suggests Active Biotech's TASQ drug is suitable for oral dosing

MBI-594AN enters phase IIb for treatment of acne

Complete response letter issued for MedImmune's intranasal flu vaccine

Calpastatin overexpression prevents myocardial injury in rat transplant model

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 20, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...